Figure 2From: Low Percentage of KRAS Mutations Revealed by Locked Nucleic Acid Polymerase Chain Reaction: Implications for Treatment of Metastatic Colorectal CancerComparison of mutation frequencies detected by sequencing/TheraScreen and the LNA-PCR methods. Distribution of KRAS-mutated and KRAS wild-type mCRC cases with sequencing/TheraScreen (left) and the LNA-PCR assays (right).Back to article page